drugset / Trial / NCT01803035
A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy of the topical antibiotic LTX-109 in terms of clinical and microbiological response in treatment of impetigo.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-03
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LTX-109 | Peptide | 1 % | Topical |
| Subject | LTX-109 | Peptide | 2 % | Topical |